Use of a Thrombin Fibrin Sealant in Reducing Blood Loss in Revision Hip Arthroplasty
Open Access
- 5 October 2015
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Orthopaedics Journal
- Vol. 9 (1) , 511-514
Abstract
We present a retrospective evaluation assessing the use of a novel fibrin sealant, Quixil ® (OMRIX Biopharmaceuticals S.A.) in reducing blood transfusions following revision total hip replacement surgery. Forty four patients underwent revision total hip replacement surgery using Quixil ® , while 45 patients underwent revision total hip replacement surgery without the use of Quixil ® . The duration of surgery and patient demographics were similar in both groups. Average blood loss was 1,010ml in the Quixil ® group versus 1,021ml in the non-Quixil group. The use of cell saver and intra-operative blood transfusion were similar in both groups. The mean pre-operative Haemoglobin was 13.0 g/dl in the Quixil ® group versus 12.4 g/dl in the non-Quixil group. The mean post-operative haemoglobin was 10.2 g/dl and 9.1 g/dl in the Quixil ® and non-Quixil groups respectively. There was no difference in the blood transfused post-operatively between the two groups. Total units of blood transfused in Quixil ® versus non-Quixil group were 60 verus 86. Total units of intra-operative blood transfused in Quixil ® versus non-Quixil group were 16 versus 23. The use of fibrin tissue adhesive in revision total hip arthroplasty seems to be an effective and reliable means to reduce blood-transfusion requirements and prevent post-operative decreases in hemoglobin.Keywords
This publication has 20 references indexed in Scilit:
- Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion2011
- The Role of Fibrin Sealants in Orthopaedic SurgeryJournal of the American Academy of Orthopaedic Surgeons, 2009
- Analysing uncertainty around costs of innovative medical technologies: The case of fibrin sealant (QUIXIL®) for total knee replacementHealth Policy, 2009
- Strategies for blood management in orthopaedic and trauma surgeryThe Journal of Bone and Joint Surgery. British volume, 2008
- The Use of Antifibrinolytic Agents in Total Hip ArthroplastyThe Journal of Arthroplasty, 2006
- Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients.2005
- Comparison of a New Fibrin Sealant With Standard Topical Hemostatic AgentsArchives of Surgery, 2004
- Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indicationsBritish Journal of Anaesthesia, 2004
- Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusionBritish Journal of Surgery, 2002
- Aprotinin Decreases Blood Loss in Patients Undergoing Revision or Bilateral Total Hip ArthroplastyAnesthesia & Analgesia, 1995